Peptide half-lives and dosing cadence
Reviewed by the Rite Aid Health Team · Last updated August 14, 2026
Half-life is the time required for the measured amount of a drug in the body to fall by half. It helps explain dosing cadence, but receptor effects, active metabolites, formulation, and the clinical goal also shape a schedule.
Use the exact directions for the prescribed product. The required diluent, concentration, injection route, storage, and discard date can differ by formulation.
Get the Free Peptide Tracking Toolkit
Pair this Half-lives guide with a broader peptide overview and an Excel workbook for the details you verify.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Free download
Useful before or after you start
- Before you start, compare the details that matter and build a focused question list.
- Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
- Separate your schedule from what actually happened, so important dates are easier to spot.
- Keep your private working copy on your own device.
Confirm your email to receive both downloads and your personal 20% off coupon.
Almost done
We sent the first email to .
Confirm your email to get the toolkit and your 20% off coupon.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then the toolkit arrives
We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Tell us where to send it
Free, no spam, only peptide news that matters. Unsubscribe anytime.
At a glance
| Peptide or medicine | Approximate half-life | Evidence-based context |
|---|---|---|
| Tesamorelin | About 8 minutes after repeated EGRIFTA WR dosing | Once daily in approved labeling. EGRIFTA WR label |
| CJC-1295 with DAC | About 6 to 8 days in the cited pharmacokinetic study | The study measured prolonged exposure and growth-hormone-axis effects; it did not establish a wellness schedule. Human study |
The table is limited to values supported by an identifiable product label or primary human study. Values depend on the exact molecule, assay, population, and formulation.
Short half-life does not always mean frequent treatment
A short blood half-life can trigger a biological signal that lasts longer than the compound itself. Tesamorelin is one example: the measured drug clears quickly, while the downstream growth-hormone and IGF-1 response supports labeled once-daily dosing.
Small naming changes can create large schedule changes
CJC-1295 with DAC and Mod GRF 1-29 are the clearest example. DAC extends exposure from minutes to days. A vial described only as “CJC” does not identify which half-life or schedule applies.
Use labeled cadence for approved medicines
Approved dosing combines pharmacokinetics with controlled trials, formulation testing, and safety monitoring. For experimental compounds, a reported schedule may reflect convenience or convention rather than a demonstrated clinical endpoint.
Related
Sources
Get the Free Peptide Tracking Toolkit
Pair this Half-lives guide with a broader peptide overview and an Excel workbook for the details you verify.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Free download
Useful before or after you start
- Before you start, compare the details that matter and build a focused question list.
- Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
- Separate your schedule from what actually happened, so important dates are easier to spot.
- Keep your private working copy on your own device.
Confirm your email to receive both downloads and your personal 20% off coupon.
Almost done
We sent the first email to .
Confirm your email to get the toolkit and your 20% off coupon.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then the toolkit arrives
We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Tell us where to send it
Free, no spam, only peptide news that matters. Unsubscribe anytime.
For general education only — not medical advice or a treatment recommendation. Peptides are not a substitute for care from a licensed provider. Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement.
FAQ
No. It means exposure lasts longer. Benefit depends on the molecule, dose, formulation, population, and outcome.
The DAC modification binds CJC-1295 to albumin and extends exposure for days. Mod GRF 1-29 is short acting.
No. Dosage also depends on concentration, biological response, clinical evidence, safety, and product instructions.